financetom
Business
financetom
/
Business
/
China commerce minister says he met Nvidia CEO in Beijing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
China commerce minister says he met Nvidia CEO in Beijing
Jul 17, 2025 9:48 PM

BEIJING, July 18 (Reuters) - China's Commerce Minister

Wang Wentao said on Friday he met with Nvidia ( NVDA ) CEO

Jensen Huang in Beijing on Thursday.

Wang said at a press conference that Huang had worked very

hard over the past few days during his visit to China, but Wang

did not provide any details about what was discussed at their

meeting.

Nvidia ( NVDA ) did not respond immediately to a request for comment.

During his third China visit this year, Huang, the founder

and CEO of the world's most valuable company, also met with Ren

Hongbin, chairman of China Council for the Promotion of

International Trade and the country's Vice Premier He Lifeng.

Chinese officials told Huang they welcomed foreign companies

to continue to invest in the country, the Nvidia ( NVDA ) CEO said at a

press conference in Beijing on Wednesday.

At the event, Huang described artificial intelligence models

from Chinese firms Deepseek, Alibaba ( BABA ) and Tencent ( TCTZF )

as "world class" and said AI was "revolutionising"

supply chains.

Huang also said Chinese customers' demand for its H20 AI

chip, which was released from U.S. export controls this week, is

high but no purchase orders have been fulfilled yet as it awaits

U.S. government approval for export licences.

Nvidia ( NVDA ) has also announced it is developing a new chip for

Chinese clients called the RTX Pro GPU, which would be compliant

with U.S. export restrictions and designed specifically for

smart factories and for robot training purposes.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
Exclusive-Worldline attracts early stage interest from private equity firms, sources say
Dec 2, 2024
LONDON (Reuters) -French payments group Worldline has attracted early stage takeover interest from private equity firms, as it grapples with a falling share price, profit warnings and leadership change, five people with knowledge of the matter said. Bain Capital is among private equity firms that have been in the initial stages of evaluating a possible bid for Worldline, two of...
Carrier Completes $3 Billion Sale of Commercial, Residential Fire Business to Lone Star Funds' Affiliate
Carrier Completes $3 Billion Sale of Commercial, Residential Fire Business to Lone Star Funds' Affiliate
Dec 2, 2024
09:27 AM EST, 12/02/2024 (MT Newswires) -- Carrier Global ( CARR ) said Monday it has completed the sale of its commercial and residential fire business to an affiliate of Lone Star Funds for an enterprise value of $3 billion. The company intends to use the expected $2.2 billion net proceeds from the sale to finance stock buybacks, with at...
Community Health's Northwest Urgent Care Unit Acquires Carbon Health Centers in Arizona
Community Health's Northwest Urgent Care Unit Acquires Carbon Health Centers in Arizona
Dec 2, 2024
09:34 AM EST, 12/02/2024 (MT Newswires) -- Community Health Systems ( CYH ) said Monday its Northwest Urgent Care unit has completed the acquisition of certain urgent care centers operated by Carbon Health in Arizona. The acquisition expands Northwest Healthcare's network to over 80 care sites in Tucson and surrounding area, Community Health ( CYH ) said. Price: 3.40, Change:...
Rigel Pharmaceuticals Says its R289 Hematology Drug Candidate Receives Fast-Track Designation From US FDA
Rigel Pharmaceuticals Says its R289 Hematology Drug Candidate Receives Fast-Track Designation From US FDA
Dec 2, 2024
09:27 AM EST, 12/02/2024 (MT Newswires) -- Rigel Pharmaceuticals ( RIGL ) early Monday said the US Food and Drug Administration has granted fast track designation for the company's R289 drug candidate for the treatment of patients with previously treated transfusion dependent lower-risk myelodysplastic syndrome. Myelodysplastic syndrome is a cancer that causes bone marrow to produce abnormal or immature blood...
Copyright 2023-2026 - www.financetom.com All Rights Reserved